mRNA |
barasertib |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
MK 1775 |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
SR1001 |
CTRPv2 |
pan-cancer |
AAC |
-0.02 |
0.6 |
mRNA |
C6-ceramide |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
SKI-II |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K02492147 |
CTRPv2 |
pan-cancer |
AAC |
-0.021 |
0.6 |
mRNA |
selumetinib:MK-2206 (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.037 |
0.6 |
mRNA |
HC-067047 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |